Dr. Uhl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11 Sessions Road
Lafayette, CA 94549Phone+1 510-421-7808
Education & Training
- University of California (San Francisco)Residency, Radiation Oncology, 1986 - 1990
- University of California (San Francisco)Fellowship, Radiation Oncology, 1987 - 1988
- University of California (San Francisco)/FresnoInternship, Transitional Year, 1985 - 1986
- University of California San Francisco School of MedicineClass of 1985
Certifications & Licensure
- CA State Medical License 1987 - 2025
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 493 citationsPhase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Grou...Mack Roach, M. DeSilvio, C. Lawton, Valery Uhl, Mitchell Machtay
Journal of Clinical Oncology. 2003-05-15 - 346 citationsAn Update of the Phase III Trial Comparing Whole Pelvic to Prostate Only Radiotherapy and Neoadjuvant to Adjuvant Total Androgen Suppression: Updated Analysis of RTOG ...Colleen A. Lawton, Michelle DeSilvio, Mack Roach, Valery Uhl, Robert Kirsch
International Journal of Radiation Oncology, Biology, Physics. 2007-11-01 - 3 citationsThe TARGIT-A Randomized Trial: TARGIT-IORT Versus Whole Breast Radiation Therapy: Long-Term Local Control and Survival.Jayant S Vaidya, Max Bulsara, Frederik Wenz, Elena Sperk, Samuele Massarut
International Journal of Radiation Oncology, Biology, Physics. 2023-01-01
Press Mentions
- Single-Dose Radiation Therapy for Breast Cancer Removes Treatment Barriers for Underserved Black WomenFebruary 18th, 2021
- TARGIT-IORT Long-Term Data Demonstrates Equivalent Outcomes to Traditional 3- to 6-Week Radiotherapy, Significantly Reducing COVID-19 Risk to Patients Amidst Coming SurgeDecember 17th, 2020
- Single-Dose Radiation Therapy at Time of Lumpectomy Helps Breast Cancer Patients Overcome Treatment Challenges During PandemicDecember 2nd, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: